sarcomere

German anatomist Wilhelm Krause coined 'sarcomere' in 1869 from two Greek words: sarx (flesh) and meros (part or share). Krause was working at the University of Göttingen, examining striated muscle under compound light microscopes that had become powerful enough to resolve the banding patterns of individual fibers. He named the repeating unit between two Z-lines a Sarkomer, and the term passed into English as sarcomere within a decade. The word was precise from birth: it named not a vague tissue type but a single, bounded, repeating structural segment.

The sarcomere is roughly 2.5 micrometers long in resting human muscle, a length that Krause could estimate but not measure accurately with 1869 technology. What he could see clearly was the alternating dark and light bands produced by the overlapping arrangement of thick myosin filaments and thin actin filaments. Those bands gave striated (striped) muscle its name and gave histologists a visual signature to follow from species to species. By 1900, researchers had catalogued sarcomere banding patterns in insects, fish, birds, and mammals, finding the same architecture everywhere voluntary movement existed.

The functional explanation for those bands arrived in 1954, when Andrew Huxley and Rolf Niedergerke published in Nature their sliding filament model of muscle contraction. Simultaneously, Hugh Huxley and Jean Hanson published a complementary account from MIT. The two Huxleys (unrelated to each other) showed that the sarcomere's length changes during contraction not because the filaments themselves shorten, but because they slide past one another, driven by myosin heads repeatedly binding, pulling, and releasing actin. A sarcomere shortens; the filaments inside it do not.

Every striated muscle contraction in every animal with voluntary movement runs through sarcomeres. The human heart contains approximately two billion of them per gram of cardiac muscle. Research into sarcomere mutations has identified the molecular basis of hypertrophic cardiomyopathy, a leading cause of sudden cardiac death in athletes. The word Krause invented in 1869 is now the site of some of the most consequential research in cardiovascular medicine, carrying the weight of two Greek syllables into the era of gene sequencing.